Bach Option’s Amgen AMGN Stock Holding History

Bach Option’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,319	Closed	-$223K	–	157
2016 Q2	$201K	Buy	+1,319	New	+$205K	0.08%	159

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bach Option's AMGN Position: Q3 2016 in Review

Bach Option sold out of Amgen (AMGN) in Q3 2016, closing a stake of 1,319 shares — an estimated $223K sold.

Bach Option first reported a position in AMGN in Q2 2016 and held it in 1 quarter. The position peaked at $201K in Q2 2016. 1,517 funds tracked by Wall St. Rank hold AMGN as of Q3 2016.

Bach Option reported no remaining Amgen position as of Q3 2016 after selling out during the quarter.
Bach Option sold 1,319 Amgen shares in Q3 2016, an estimated $223K.
Bach Option first reported a position in Amgen in Q2 2016 and held it in 1 quarter.
Bach Option's Amgen position peaked at $201K in Q2 2016.
1,517 funds tracked by Wall St. Rank held Amgen as of Q3 2016.

Based on Bach Option's 13F filing for Q3 2016, filed 18 Oct 2016.